00:00 - Introduction to the Estimands Academy for Trial teams and this webinar
01:24 - The presenters and panelists
03:43 - Publication: Realizing the benefits of the estimand framework when reporting and communicating clinical trial results – some recommendations
05:17 - Describing and Reporting Treatment Effects of Interest
16:34 - Treatment Effects in Study Reports and Submission Documents
30:46 - Estimands in Public Clinical Trial Registries
41:05 - Closing remarks
42:35 Q&A
In this webinar we explore practical strategies for applying the estimand framework in clinical study reporting. Drawing on real-world experiences and case studies, we will share recommendations to
• Understand the role of estimands in improving transparency and interpretation of trial results.
• Navigate common challenges in implementing the framework during reporting.
• Apply best practices to enhance regulatory submissions, webposting in public registries (clinicaltrials.gov/CTIS), and scientific publications.
The webinar targets drug developers involved in clinical trial design, data analysis, or regulatory submissions, who are interested in realizing the full potential of the estimand framework
Publication: Lanius V, Glocker B, Lösch C, Bratton DJ, Callegari F, Wright M, Rajamäki S. Realizing the benefits of the estimand framework when reporting and communicating clinical trial results-some recommendations. Trials. 2025 Jul 11;26(1):241. doi: 10.1186/s13063-025-08915-6. PMID: 40640873; PMCID: PMC12247363.